Arabic AR Chinese (Simplified) ZH-CN English EN French FR German DE Japanese JA Portuguese PT Russian RU Spanish ES Ukrainian UK

Breaking

Shkreli’s bros: Drug company raises everyday vitamin price by 800 percent

Latest news

    View the original article: https://www.rt.com/usa/412903-drug-company-vitamin-price-hike/?utm_source=rss&utm_medium=rss&utm_campaign=RSS

    Following the lead of pharma-bro Martin Shkreli, a US drug company has hiked the price of a prescription version of vitamin B3 pills by over 800 percent. A drug used to treat respiratory ailments also got a price hike of nearly 2,500 percent.

    Avondale Pharmaceuticals raised the price of Niacor, a prescription-only version of niacin (vitamin B3), by 809 percent last month. This means a bottle of 100 tablets went from costing $32.46 to $295, according to figures sent to the Financial Times.

    While the drug is available over the counter, some doctors prefer to prescribe a version that has US Food and Drug Administration approval. The drug is used to lower cholesterol to reduce the chance of having a heart attack.

    The company also acquired another generic, SSKI, and increased its price by 2,499 percent, taking a 30ml bottle from $11.48 to $295.

    The Birmingham, Alabama-based company raised its prices shortly after acquiring the rights to the drugs in a “buy-and-raise” deal made notorious by Martin Shkreli, the hedge fund investor recently convicted of securities fraud.

    Shkreli became mired in controversy when he raised the price of a drug used by cancer and HIV patients by 5,500 percent.

    Read more

    9 Big Pharma rip-offs 'worse than Martin Shkreli'

    The price hikes by Avondale were first noticed by Truven Health Analytics, according to The Independent.

    According to the Financial Times, Avondale Pharmaceuticals was set up in August by a registered agent, Acrogen Pharmaceuticals, seemingly for the sole purpose of drug acquisition. Acrogen was started in 2016 by Mark Pugh, an executive behind several pharmaceutical companies.

    “This is the latest example of an inefficient US market where the consumer, payer, and doctor don’t have all the information available to make a financially sound choice,” Michael Rae, CEO of Rx Savings, told FT. “They are caught in a web of inefficiency and are being taken advantage of.”

    Price gouging is a controversial but established strategy whereby firms buy up the rights to a drug that faces little or no competition, before massively inflating the price and enjoying the profits.

    In the same category are

    Democrats try to justify their election defeat by filing lawsuit against Russia & Trump – Moscow The Democratic National Committee lawsuit against the Trump campaign, the Russian government and WikiLeaks looks like an attempt to justify the Democr...
    Israel’s Mossad accused of assassinating Palestinian ‘rocket scientist’ in Malaysia The family of a Palestinian lecturer, allegedly linked to a Hamas drone and rocket program, has accused Mossad of his murder in Kuala Lumpur. Malaysia...
    Robots & APCs: Anti-terrorist units eliminate nine militants in Russia’s Dagestan (VIDEO) Operatives of the Federal Security Service (FSB) deployed a tiny machinegun-wielding robot along with armored vehicles as they engaged with a group of...
    Hungarian protesters rally for ‘press freedom & Orban regime change’ (PHOTOS, VIDEOS) Thousands of protesters attended a massive rally in Budapest, to defend “free press” and to oppose Viktor Orban’s “regime,” which, after its recent la...
    Terrorists attack Libyan oil pipeline, crippling daily crude output by up to 100k barrels A Libya crude oil pipeline, belonging to the al-Waha oil company and running to Sidra port, was attacked and set on fire by an unknown “terrorist grou...
    OPCW confirms visit to site of alleged chemical attack in Syria The OPCW confirmed that a team visited the site in Douma where an alleged chemical attack took place. The Russian Foreign Ministry has voiced concerns...

    Leave a comment

    Your email address will not be published. Required fields are marked *